{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:23:01Z","timestamp":1790256181582,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (AR)","award":["PIP-2012-517"],"award-info":[{"award-number":["PIP-2012-517"]}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y T\u00e9cnica (ANPCyT)","doi-asserted-by":"crossref","award":["(PICT-2014-1566)"],"award-info":[{"award-number":["(PICT-2014-1566)"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13277-016-5259-8","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T05:08:07Z","timestamp":1469768887000},"page":"13637-13647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides"],"prefix":"10.1007","volume":"37","author":[{"given":"Fuad Huaman","family":"Garaicoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Roisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Trila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fridmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Abelda\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vanzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Narbaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Slavutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"5259_CR1","first-page":"296","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"E Ralfkiaer","year":"2008","unstructured":"Ralfkiaer E, Cerroni L, Sander CA, Smoller BR, Willemze R. Mycosis fungoides. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer Press; 2008. p. 296\u20138."},{"key":"5259_CR2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","volume":"170","author":"JJ Scarisbrick","year":"2014","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, et al. Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now? Br J Dermatol. 2014;170:1226\u201336.","journal-title":"Br J Dermatol"},{"key":"5259_CR3","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 2012;119:1643\u20139.","journal-title":"Blood"},{"key":"5259_CR4","first-page":"299","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"E Ralfkiaer","year":"2008","unstructured":"Ralfkiaer E, Willemze R, Whittaker SJ. S\u00e9zary syndrome. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer Press; 2008. p. 299."},{"key":"5259_CR5","doi-asserted-by":"crossref","first-page":"913523","DOI":"10.1155\/2012\/913523","volume":"2012","author":"PW Raess","year":"2012","unstructured":"Raess PW, Bagg A. The role of molecular pathology in the diagnosis of cutaneous lymphomas. Pathol Res Int. 2012;2012:913523.","journal-title":"Pathol Res Int"},{"key":"5259_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","volume":"113","author":"R Doorn van","year":"2009","unstructured":"van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, et al. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood. 2009;113:127\u201336.","journal-title":"Blood"},{"key":"5259_CR7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","volume":"130","author":"R Salgado","year":"2010","unstructured":"Salgado R, Servitje O, Gallardo F, Vermeer MH, Ortiz-Romero PL, Karpova MB, et al. Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol. 2010;130:1126\u201335.","journal-title":"J Invest Dermatol"},{"key":"5259_CR8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","volume":"130","author":"E Laharanne","year":"2010","unstructured":"Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E, et al. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol. 2010;130:1707\u201318.","journal-title":"J Invest Dermatol"},{"key":"5259_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(99)80004-5","volume":"9","author":"NE Sharpless","year":"1999","unstructured":"Sharpless NE, DePinho RA. The INK4A\/ARF locus and its two gene products. Curr Opin Genet Dev. 1999;9:22\u201330.","journal-title":"Curr Opin Genet Dev"},{"key":"5259_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1101\/sqb.2005.70.005","volume":"70","author":"M Barbacid","year":"2005","unstructured":"Barbacid M, Ortega S, Sotillo R, Odajima J, Mart\u00edn A, Santamar\u00eda D, et al. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases. Cold Spring Harb Symp Quant Biol. 2005;70:233\u201340.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"5259_CR11","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","volume":"18","author":"MF Roussel","year":"1999","unstructured":"Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 1999;18:5311\u20137.","journal-title":"Oncogene"},{"key":"5259_CR12","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","volume":"91","author":"M Pinyol","year":"1998","unstructured":"Pinyol M, Cobo F, Be\u00e1 S, Jares P, Nayach I, Fernandez PL, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin\u2019s lymphomas. Blood. 1998;91:2977\u201384.","journal-title":"Blood"},{"key":"5259_CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.seminoncol.2005.07.001","volume":"32","author":"R Doorn van","year":"2005","unstructured":"van Doorn R, Gruis NA, Willemze R, van der Velden PA, Tensen CP. Aberrant DNA methylation in cutaneous malignancies. Semin Oncol. 2005;32:479\u201387.","journal-title":"Semin Oncol"},{"key":"5259_CR14","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1158\/1078-0432.CCR-07-2033","volume":"14","author":"JD Licchesi","year":"2008","unstructured":"Licchesi JD, Westra WH, Hooker CM, Herman JG. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res. 2008;14:2570\u20138.","journal-title":"Clin Cancer Res"},{"key":"5259_CR15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","volume":"23","author":"E Laharanne","year":"2010","unstructured":"Laharanne E, Chevret E, Idrissi Y, Gentil C, Longy M, Ferrer J, et al. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Mod Pathol. 2010;23:547\u201358.","journal-title":"Mod Pathol"},{"key":"5259_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","volume":"172","author":"AR Nicolae-Cristea","year":"2016","unstructured":"Nicolae-Cristea AR, Benner MF, Zoutman WH, Zoutman WH, van Eijk R, Jansen PM, et al. Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease. Br J Dermatol. 2016;172:784\u20138.","journal-title":"Br J Dermatol"},{"key":"5259_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149:22\u201335.","journal-title":"Cell"},{"key":"5259_CR18","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","volume":"122","author":"G Ott","year":"2013","unstructured":"Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood. 2013;122:3884\u201391.","journal-title":"Blood"},{"key":"5259_CR19","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","volume":"27","author":"B Hoffman","year":"2008","unstructured":"Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene. 2008;27:6462\u201372.","journal-title":"Oncogene"},{"key":"5259_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","volume":"15","author":"KV Morris","year":"2014","unstructured":"Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423\u201337.","journal-title":"Nat Rev Genet"},{"key":"5259_CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321\u201333.","journal-title":"Nat Rev Cancer"},{"key":"5259_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOH.0b013e3283476012","volume":"18","author":"M Fabbri","year":"2011","unstructured":"Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol. 2011;18:266\u201372.","journal-title":"Curr Opin Hematol"},{"key":"5259_CR23","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B-cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5259_CR24","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD, et al. Differentiation stage specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood. 2009;113:3754\u201364.","journal-title":"Blood"},{"key":"5259_CR25","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1073\/pnas.1101795108","volume":"108","author":"E Tili","year":"2011","unstructured":"Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011;108:4908\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5259_CR26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic\/microRNA-155 for normal immune function. Science. 2007;316:608\u201311.","journal-title":"Science"},{"key":"5259_CR27","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","volume":"12","author":"KL Kopp","year":"2013","unstructured":"Kopp KL, Ralfkiaer U, Gjerdrum LM, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle. 2013;12:1939\u201347.","journal-title":"Cell Cycle"},{"key":"5259_CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","volume":"5","author":"MS Kester van","year":"2011","unstructured":"van Kester MS, Ballabio E, Benner MF, Helvad R, Pedersen IH, Litman T, et al. miRNA expression profiling of mycosis fungoides. Mol Oncol. 2011;5:273\u201380.","journal-title":"Mol Oncol"},{"key":"5259_CR29","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","volume":"118","author":"U Ralfkiaer","year":"2011","unstructured":"Ralfkiaer U, Hagedorn PH, Bangsgaard N, L\u00f8vendorf MB, Ahler CB, Svensson L, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma. Blood. 2011;118:5891\u2013900.","journal-title":"Blood"},{"key":"5259_CR30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2011.10669.x","volume":"166","author":"J Maj","year":"2012","unstructured":"Maj J, Jankowska-Konsur A, Sadakiewska-Chudy A, Noga L, Reich A. Altered microRNA expression in mycosis fungoides. Br J Dermatol. 2012;166:331\u20136.","journal-title":"Br J Dermatol"},{"key":"5259_CR31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/exd.12161","volume":"2","author":"L Moyal","year":"2013","unstructured":"Moyal L, Barzilai A, Gorovitz B, Hirshberg A, Amariglio N, Jacob-Hirsch J, et al. miR-155 is involved in tumor progression of mycosis fungoides. Exp Dermatol. 2013;2:431\u20133.","journal-title":"Exp Dermatol"},{"key":"5259_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6605037","volume":"101","author":"B Diosdado","year":"2009","unstructured":"Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer. 2009;101:707\u201314.","journal-title":"Br J Cancer"},{"key":"5259_CR33","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628\u201332.","journal-title":"Cancer Res"},{"key":"5259_CR34","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","volume":"69","author":"A Navarro","year":"2009","unstructured":"Navarro A, Be\u00e1 S, Fern\u00e1ndez V, Prieto M, Salaverria I, Jares P, et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in mantle cell lymphomas. Cancer Res. 2009;69:7071\u20138.","journal-title":"Cancer Res"},{"key":"5259_CR35","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1349-7006.2007.00531.x","volume":"9","author":"H Tagawa","year":"2007","unstructured":"Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. Synergistic action of the microRNA-17 polycistron and myc in aggressive cancer development. Cancer Sci. 2007;9:1482\u201390.","journal-title":"Cancer Sci"},{"key":"5259_CR36","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1371\/journal.pgen.0030146","volume":"3","author":"HA Coller","year":"2007","unstructured":"Coller HA, Forman JJ, Legesse-Miller A. \"Myc\u2019ed messages\": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet. 2007;3:e146.","journal-title":"PLoS Genet"},{"key":"5259_CR37","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1038\/sj.onc.1210425","volume":"41","author":"H Matsubara","year":"2007","unstructured":"Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene. 2007;41:6099\u2013105.","journal-title":"Oncogene"},{"key":"5259_CR38","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of cancer (EORTC). Blood. 2007;110:1713\u201322.","journal-title":"Blood"},{"key":"5259_CR39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 22DDCT. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"5259_CR40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.20302","volume":"45","author":"DA Batista","year":"2006","unstructured":"Batista DA, Vonderheid EC, Hawkins A, Morsberger L, Long P, Murphy KM, et al. Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and S\u00e9zary syndrome: search for recurrent chromosome abnormalities. Genes Chrom Cancer. 2006;45:383\u201391.","journal-title":"Genes Chrom Cancer"},{"key":"5259_CR41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.0022-202X.2004.22301.x","volume":"122","author":"TC Fischer","year":"2004","unstructured":"Fischer TC, Gellrich S, Muche JM, Sherev T, Audring H, Neitzel H, et al. Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol. 2004;122:579\u201386.","journal-title":"J Invest Dermatol"},{"key":"5259_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/labinvest.3780405","volume":"82","author":"IC Navas","year":"2002","unstructured":"Navas IC, Algara P, Mateo M, Mart\u00ednez P, Garc\u00eda C, Rodriguez JL, et al. p16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides. Lab Invest. 2002;82:123\u201332.","journal-title":"Lab Invest"},{"key":"5259_CR43","first-page":"284","volume":"17","author":"A Abelda\u00f1o","year":"2011","unstructured":"Abelda\u00f1o A, Benedetti A, Maskin M, Arias M, Ochoa K, Brea P, et al. S\u00edndromes linfoproliferativos CD30+. Serie de 26 casos y revisi\u00f3n de la literatura. Dermatol Argent. 2011;17:284\u201393.","journal-title":"Dermatol Argent"},{"key":"5259_CR44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","volume":"139","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Jansen PM, Kinney MC, Swerdlow SH, Willemze R. Non\u2013mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology\/European Association for Haematopathology Workshop. Am J Clin Pathol. 2013;139:491\u2013514.","journal-title":"Am J Clin Pathol"},{"key":"5259_CR45","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","volume":"33","author":"JT Edinger","year":"2009","unstructured":"Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH. CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol. 2009;33:1860\u20138.","journal-title":"Am J Surg Pathol"},{"key":"5259_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2007.08008.x","volume":"157","author":"E Barberio","year":"2007","unstructured":"Barberio E, Thomas L, Skowron F, Balme B, Dalle S. Transformed mycosis fungoides: clinico-pathological features and outcome. Br J Dermatol. 2007;157:284\u20139.","journal-title":"Br J Dermatol"},{"key":"5259_CR47","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","volume":"112","author":"SO Arulogun","year":"2008","unstructured":"Arulogun SO, Prince HM, Ng J, Ryan GF, Blewitt O, McCormack C. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood. 2008;112:3082\u20137.","journal-title":"Blood"},{"key":"5259_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08830180903093796","volume":"28","author":"E Tili","year":"2009","unstructured":"Tili E, Croce CM, Michaille JJ. MiR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol. 2009;28:264\u201384.","journal-title":"Int Rev Immunol"},{"key":"5259_CR49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.4539","volume":"236","author":"O Merkel","year":"2015","unstructured":"Merkel O, Hamacher F, Griessl R, Grabner L, Schiefer AI, Prutsch N, et al. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. J Pathol. 2015;236:445\u201356.","journal-title":"J Pathol"},{"key":"5259_CR50","first-page":"7207","volume":"34","author":"U Ralfkiaer","year":"2014","unstructured":"Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, et al. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res. 2014;34:7207\u201317.","journal-title":"Anticancer Res"},{"key":"5259_CR51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s12253-015-9897-8","volume":"21","author":"D Marosv\u00e1ri","year":"2015","unstructured":"Marosv\u00e1ri D, T\u00e9gl\u00e1si V, Csala I, Marschalk\u00f3 M, B\u00f6d\u00f6r C, Tim\u00e1r B, et al. Altered microRNA expression in folliculotropic and transformed mycosis fungoides. Pathol Oncol Res. 2015;21:821\u20135.","journal-title":"Pathol Oncol Res"},{"key":"5259_CR52","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/gb-2008-9-8-r127","volume":"9","author":"N Cloonan","year":"2008","unstructured":"Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, et al. The miR-17-5p microRNA is a key regulator of the G1\/S phase cell cycle transition. Genome Biol. 2008;9:R127.","journal-title":"Genome Biol"},{"key":"5259_CR53","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0811166106","volume":"105","author":"BD Aguda","year":"2008","unstructured":"Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A. 2008;105:19678\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5259_CR54","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"7","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;7:2257\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5259_CR55","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1128\/MCB.00242-06","volume":"21","author":"A Hossain","year":"2006","unstructured":"Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006;21:8191\u2013201.","journal-title":"Mol Cell Biol"},{"key":"5259_CR56","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","volume":"13","author":"CH Lawrie","year":"2009","unstructured":"Lawrie CH, Chi J, Taylor S, Tramonti D, Tramonti D, Ballabio E, Palazzo S, et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med. 2009;13:1248\u201360.","journal-title":"J Cell Mol Med"},{"key":"5259_CR57","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","volume":"21","author":"J Iqbal","year":"2012","unstructured":"Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, et al. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood. 2012;21:4939\u201348.","journal-title":"Blood"},{"key":"5259_CR58","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","volume":"2","author":"MG Narducci","year":"2011","unstructured":"Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis. 2011;2:e151.","journal-title":"Cell Death Dis"},{"key":"5259_CR59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mc.21879","volume":"6","author":"KJ Humphreys","year":"2013","unstructured":"Humphreys KJ, Cobiac L, Le Leu RK, Van der Hoek MB, Michael MZ. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog. 2013;6:459\u201374.","journal-title":"Mol Carcinog"},{"key":"5259_CR60","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","volume":"23","author":"P Mu","year":"2009","unstructured":"Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17\u00a0\u223c\u00a092 cluster of microRNAs in myc-induced B-cell lymphomas. Genes Dev. 2009;23:2806\u201311.","journal-title":"Genes Dev"},{"key":"5259_CR61","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","volume":"23","author":"V Olive","year":"2009","unstructured":"Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009;23:2839\u201349.","journal-title":"Genes Dev"},{"key":"5259_CR62","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3892\/or.2012.1970","volume":"5","author":"H Niu","year":"2012","unstructured":"Niu H, Wang K, Zhang A, Yang S, Song Z, Wang W, et al. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncol Rep. 2012;5:1771\u20137.","journal-title":"Oncol Rep"},{"key":"5259_CR63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2011.05.017","volume":"1","author":"L Chen","year":"2011","unstructured":"Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, et al. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Lett. 2011;1:62\u201370.","journal-title":"Cancer Lett"},{"key":"5259_CR64","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","volume":"122","author":"C Cristofoletti","year":"2013","unstructured":"Cristofoletti C, Picchio MC, Lazzeri C, Tocco V, Pagani E, Bresin A, et al. Comprehensive analysis of PTEN status in Sezary syndrome. Blood. 2013;122:3511\u201320.","journal-title":"Blood"},{"key":"5259_CR65","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","volume":"116","author":"E Ballabio","year":"2010","unstructured":"Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood. 2010;116:1105\u201313.","journal-title":"Blood"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5259-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T14:23:49Z","timestamp":1600957429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5259"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5259-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}